Prevention of Combat-related PTSD Using Attention Bias Modification (ABM): A Randomized Controlled Trial

NACompletedINTERVENTIONAL
Enrollment

862

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
PTSD
Interventions
BEHAVIORAL

Active ABMT8

Active ABMT8 8 active ABMT sessions (10 min. each, over 7-8 weeks) designed to promote adaptive threat attendance

BEHAVIORAL

Active ABMT4

Active ABMT4 4 active ABMT sessions (10 min. each, over 7-8 weeks) designed to promote adaptive threat attendance

BEHAVIORAL

Placebo

Placebo: will receive 4 training sessions(10 min. each, over 7-8 weeks) using the same task and stimuli as in the active arms, but not designed to change attention patterns

Trial Locations (1)

Unknown

IDF Military camps, Beersheba

All Listed Sponsors
collaborator

Medical Corps, Israel Defense Force

OTHER

collaborator

Walter Reed Army Institute of Research (WRAIR)

FED

lead

Tel Aviv University

OTHER

NCT01723215 - Prevention of Combat-related PTSD Using Attention Bias Modification (ABM): A Randomized Controlled Trial | Biotech Hunter | Biotech Hunter